The LDH-B promoter is hypermethylated in breast and prostate cancers [17, 18], and PP treatment results in down-regulation of LDH-A in four different breast cancer cell lines and up-regulation LDH-B in three cell lines. Here, LDHB is linked to breast carcinoma.